IONIS PHARMACEUT reported $56.46M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
Arrowhead Research ARWR:US $ 17.86M 1.67M
Astellas Pharma 4503:JP 137.11B 4.16B
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Exelixis EXEL:US $ 98.49M 3.86M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Halozyme Therapeutics HALO:US $ 12.32M 1.26M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Moderna Inc MRNA:US 121M 44M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Omeros OMER:US $ 21.56M 3.51M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M